Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07669935

Advancing Stillbirth Prevention Through Innovative Risk Evaluation (ASPIRE) Clinical Study

Sponsor: Medicines360

View on ClinicalTrials.gov

Summary

ASPIRE will be a multi-site, prospective, two-part longitudinal, noninterventional observational cohort study of nulliparous singleton pregnant women to evaluate biomarkers from blood and ocular imaging for prediction of pregnancy complications \[i.e., preeclampsia (PE), fetal growth restriction (FGR), and gestational diabetes (GDM)\] and risk of adverse outcomes.

Official title: A Multi-Site, Prospective, Two-Part Longitudinal, Observational Cohort Study Of Pregnant Women To Evaluate Biomarkers For Prediction Of Pregnancy Complications

Key Details

Gender

FEMALE

Age Range

18 Years - 99 Years

Study Type

OBSERVATIONAL

Enrollment

5500

Start Date

2026-07-30

Completion Date

2028-12-01

Last Updated

2026-06-25

Healthy Volunteers

Yes

Interventions

OTHER

None (this is an observational study with no intervention)

This is an observational study to evaluateing biomarkers from blood and ocular imaging for prediction of pregnancy complications and associated risks \[i.e., preeclampsia (PE), fetal growth restriction (FGR), and gestational diabetes (GDM)\].